BiBB receives an Intention to Grant for EndoDrill patent in Europe
The cancer diagnostics company BiBBInstruments AB ("BiBB"), the developer of the world's first market-cleared electric-driven biopsy instrument for endoscopy, today announces that the Company has received an Intention to Grant from the European Patent Office (EPO). The notice means that the EPO intends to approve a divisional patent application (first patent family) in Europe for EndoDrill[®]. Certain formalities will now follow before approval, after which the patent will be valid until October 2039.BIBB has received an Intention to Grant from the EPO regarding the approval of the patent